These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19661344)

  • 1. First experiences with low-dose anti-angiogenic treatment in gliomatosis cerebri with signs of angiogenic activity.
    Seiz M; Kohlhof P; Brockmann MA; Neumaier-Probst E; Hermes P; VON Deimling A; Vajkoczy P; Schmieder K; Tuettenberg J
    Anticancer Res; 2009 Aug; 29(8):3261-7. PubMed ID: 19661344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
    Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
    Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gliomatosis cerebri: clinical, neurochemical and neuroradiological response to temozolomide administration.
    Lodi R; Setola E; Tonon C; Ambrosetto P; Franceschi E; Crinò L; Barbiroli B; Cortelli P
    Magn Reson Imaging; 2003 Nov; 21(9):1003-7. PubMed ID: 14684203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of adjuvant chemotherapy for gliomatosis cerebri.
    Kong DS; Kim ST; Lee JI; Suh YL; Lim DH; Kim WS; Kwon KH; Park K; Kim JH; Nam DH
    BMC Cancer; 2010 Aug; 10():424. PubMed ID: 20704759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gliomatosis cerebri treatment in 11 elderly patients.
    Piccirilli M; Landi A; Salvati M
    J Exp Clin Cancer Res; 2006 Jun; 25(2):183-7. PubMed ID: 16918128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gliomatosis cerebri: quantitative proof of vessel recruitment by cooptation instead of angiogenesis.
    Bernsen H; Van der Laak J; Küsters B; Van der Ven A; Wesseling P
    J Neurosurg; 2005 Oct; 103(4):702-6. PubMed ID: 16266053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procarbazine and CCNU as initial treatment in gliomatosis cerebri.
    Glas M; Rasch K; Wiewrodt D; Weller M; Herrlinger U
    Oncology; 2008; 75(3-4):182-5. PubMed ID: 18841032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gliomatosis cerebri: better definition, better treatment.
    Chamberlain MC
    Neurology; 2004 Jul; 63(2):204-5. PubMed ID: 15277608
    [No Abstract]   [Full Text] [Related]  

  • 9. NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri.
    Glas M; Bähr O; Felsberg J; Rasch K; Wiewrodt D; Schabet M; Simon M; Urbach H; Steinbach JP; Rieger J; Fimmers R; Bamberg M; Nägele T; Reifenberger G; Weller M; Herrlinger U;
    Ann Neurol; 2011 Sep; 70(3):445-53. PubMed ID: 21710625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gliomatosis cerebri: molecular pathology and clinical course.
    Herrlinger U; Felsberg J; Küker W; Bornemann A; Plasswilm L; Knobbe CB; Strik H; Wick W; Meyermann R; Dichgans J; Bamberg M; Reifenberger G; Weller M
    Ann Neurol; 2002 Oct; 52(4):390-9. PubMed ID: 12325066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer.
    Reckamp KL; Krysan K; Morrow JD; Milne GL; Newman RA; Tucker C; Elashoff RM; Dubinett SM; Figlin RA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3381-8. PubMed ID: 16740761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of presentation and failure in patients with gliomatosis cerebri treated with partial-brain radiation therapy.
    Kandula S; Saindane AM; Prabhu RS; Hanasoge S; Patel KR; Shu HK; Curran WJ; Crocker IR
    Cancer; 2014 Sep; 120(17):2713-20. PubMed ID: 24845411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gliomatosis cerebri: review of 22 patients].
    Novillo López ME; Gómez-Ibáñez A; Rosenfeld M; Dalmau J
    Neurologia; 2010 Apr; 25(3):168-73. PubMed ID: 20492863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Anti-angiogenic Chemotherapy with Temozolomide and Celecoxib in Selected Patients with Malignant Glioma Not Eligible for Standard Treatment.
    Kerschbaumer J; Schmidt FA; Grams AE; Nowosielski M; Pinggera D; Brawanski KR; Petr O; Thomé C; Tuettenberg J; Seiz M; Freyschlag CF
    Anticancer Res; 2015 Sep; 35(9):4955-60. PubMed ID: 26254394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gliomatosis cerebri: clinical characteristics, management, and outcomes.
    Chen S; Tanaka S; Giannini C; Morris J; Yan ES; Buckner J; Lachance DH; Parney IF
    J Neurooncol; 2013 Apr; 112(2):267-75. PubMed ID: 23341100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gliomatosis cerebri: report of 3 cases and review of recent literatures].
    Arai M; Kashihara K; Kaizaki Y; Taguchi M; Kitamura Y
    No To Shinkei; 2003 Oct; 55(10):890-7. PubMed ID: 14635518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebri.
    Kaloshi G; Everhard S; Laigle-Donadey F; Marie Y; Navarro S; Mokhtari K; Idbaih A; Ducray F; Thillet J; Hoang-Xuan K; Delattre JY; Sanson M
    Neurology; 2008 Feb; 70(8):590-5. PubMed ID: 18285534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gray matter involvement predicts chemosensitivity and prognosis in gliomatosis cerebri.
    Kaloshi G; Guillevin R; Martin-Duverneuil N; Laigle-Donadey F; Psimaras D; Marie Y; Mokhtari K; Hoang-Xuan K; Delattre JY; Sanson M
    Neurology; 2009 Aug; 73(6):445-9. PubMed ID: 19667319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gliomatosis cerebri].
    Sanson M; Napolitano M; Cartalat-Carel S; Taillibert S
    Rev Neurol (Paris); 2005 Feb; 161(2):173-81. PubMed ID: 15798516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin's lymphoma.
    Buckstein R; Kerbel RS; Shaked Y; Nayar R; Foden C; Turner R; Lee CR; Taylor D; Zhang L; Man S; Baruchel S; Stempak D; Bertolini F; Crump M
    Clin Cancer Res; 2006 Sep; 12(17):5190-8. PubMed ID: 16951238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.